Healthcare provider profile · identity verified

Allison L Weddle, APRN

Nurse Practitioner · BIG FALLS, MN · NPI 1497000541

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	185	58
Lisinopril	Lisinopril	133	46
Amlodipine Besylate	Amlodipine Besylate	122	40
Omeprazole	Omeprazole	104	36
Metoprolol Succinate	Metoprolol Succinate	87	25
Losartan Potassium	Losartan Potassium	85	27
Hydrochlorothiazide	Hydrochlorothiazide	83	27
Metformin Hcl	Metformin Hcl	83	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	70	23
Oxycodone Hcl	Oxycodone Hcl	69	14
Simvastatin	Simvastatin	67	20
Gabapentin	Gabapentin	59	25
Warfarin Sodium	Warfarin Sodium	57	18
Levothyroxine Sodium	Levothyroxine Sodium	56	17
Pantoprazole Sodium	Pantoprazole Sodium	54	17
Ventolin Hfa	Albuterol Sulfate	52	15
Rosuvastatin Calcium	Rosuvastatin Calcium	51	17
Fluticasone Propionate	Fluticasone Propionate	50	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	16
Duloxetine Hcl	Duloxetine Hcl	45	11
Trazodone Hcl	Trazodone Hcl	45	17
Metoprolol Tartrate	Metoprolol Tartrate	38	11
Furosemide	Furosemide	37	16
Prednisone	Prednisone	36	26
Tizanidine Hcl	Tizanidine Hcl	36	16
Allopurinol	Allopurinol	34	11
Albuterol Sulfate Hfa	Albuterol Sulfate	32	13
Tamsulosin Hcl	Tamsulosin Hcl	32	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Sertraline Hcl	Sertraline Hcl	31	11
Alendronate Sodium	Alendronate Sodium	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	14
Metformin Hcl Er	Metformin Hcl	28	suppressed
Montelukast Sodium	Montelukast Sodium	27	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Lorazepam	Lorazepam	24	12
Azithromycin	Azithromycin	23	20
Ezetimibe	Ezetimibe	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Potassium Chloride	Potassium Chloride	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	11
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Famotidine	Famotidine	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	18	13
Xarelto	Rivaroxaban	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Glipizide	Glipizide	17	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Carvedilol	Carvedilol	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	15	15
Labetalol Hcl	Labetalol Hcl	15	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Atenolol	Atenolol	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Eliquis	Apixaban	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Verapamil Er Pm	Verapamil Hcl	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Clopidogrel	Clopidogrel Bisulfate	11	suppressed
Desmopressin Acetate	Desmopressin Acetate	11	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error